LMLaura K. Mäkinen

Laura K. Mäkinen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura K. Mäkinen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Removal of parotid sialoliths; techniques, complications, and success rate—A cohort study

    by Lena Hafrén, Laura K. Mäkinen, Aaro Haapaniemi, Johanna Jokela, Riitta Saarinen


  • Open Access

    Epidemiology and aetiology of sport‐related nasal fractures: Analysis of 599 Finnish patients

    by Iida‐Kaisa Manninen, Tuomas Klockars, Laura K. Mäkinen, Karin Blomgren


  • Open Access

    The effect of fascin 1 inhibition on head and neck squamous cell carcinoma cells

    by Awais Wahab, Aini Hyytiäinen, Wafa Wahbi, Katja Tuomainen, Sanni Tervo, Pablo Conesa‐Zamora, Laura Jauhiainen, Laura K. Mäkinen, Timo Paavonen, Sanna Toppila‐Salmi, et al.

    Fascin 1 plays important pro‐metastatic roles in head and neck carcinoma (HNSCC) migration, invasion, and metastasis. However, limited advancement in targeting metastasis remains a major obstacle in improving HNSCC patients’ survival. Therefore, we assessed the therapeutic potential of fascin 1 targeted inhibition and its potential prognostic value in HNSCC patients. Using in vitro and in vivo approaches, we investigated the effect of compound G2, a novel fascin 1 inhibitor, on HNSCC cells migration, invasion, and metastasis. High‐throughput screening (HTS) was used to assess cytotoxic activity of compound G2 alone or combined with irradiation. We also evaluated the prognostic potential of fascin 1 in HNSCC patients. Interestingly, compound G2 reduced carcinoma cells migration and invasion in vitro and inhibited metastasis in vivo. Moreover, HTS revealed a modest cytotoxic activity of the compound G2 on HNSCC cell lines. Irradiation did not synergistically enhance the compound G2‐mediated cytotoxic activity. Survival analyses showed that high fascin 1 immunoexpression, at the tumor invasive front, was associated with cancer‐specific mortality in the advanced stages of HNSCC. Collectively, our findings suggest that fascin 1 represents a promising anti‐metastatic therapeutic target and a useful prognostic marker in patients with HNSCC. Novel anti‐metastatic agents could provide a valuable addition to cancer therapy.


  • Cauliflower ear among Finnish high‐level male wrestlers and judokas is prevalent and symptomatic deformity

    by Iida‐Kaisa Manninen, Karin Blomgren, Rauno Elokiuru, Mika Lehto, Laura K Mäkinen, Tuomas Klockars

    Our research aimed to study the prevalence, concerns, and treatment practices related to cauliflower ear among Finnish wrestlers and judokas. In total, 32 Finnish wrestlers and 31 judokas completed a questionnaire at training sessions or at a competition. All participants were adults competing at the national or international levels. We also took lateral digital photographs of participants’ ears. A senior author graded the overall appearance of the auricles on a scale from 0 to 5 (0 = normal auricle, 5 = extreme cauliflower ear). Cauliflower ear was more prevalent among male athletes (84%, 46/55) than female athletes (0%, 0/8, P < .001). Almost all (96%) had sought treatment for an auricular hematoma. The most prevalent treatment modality was needle aspiration (96%). Most (76%) had received treatment from individuals not representing the healthcare profession. Only one athlete reported receiving successful treatment. No complications from treatment were reported. Almost all participants (96%) reported some symptom from the cauliflower ear, typically pain. None regretted their cauliflower ear(s), and 41% of athletes with cauliflower ear considered it desirable. Cauliflower ear is a common and symptomatic deformity among high‐level Finnish wrestlers and judokas. Despite the symptoms, it is accepted and sometimes even desired among the athletes.